Phase 3, randomized, double-blind, active-controlled, parallel arm study of PRC-062 (hydromorphone/naloxone controlled release capsules) in patients with chronic non-cancer pain. To see if IP is as effective as hydromorph contin. Register Today!
Atrial Fibrillation
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multicenter, Multi-National Study For Evaluation Of Efficacy And Safety Of Du-176b Versus Warfarin In Subjects With Atrial Fibrillation – Effective Anticoagulation With Factor Xa Next Generation In Atrial Fibrillation. Register Today!
Diabetes
A phase III, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of the fixed dose combination of Empagliflozin 10 mg/Linagliptin 5 mg compared with Empagliflozin 10 mg alone and the efficacy and safety of Empagliflozin 25 mg/Linagliptin 5 mg compared with Empagliflozin 25 mg alone each administered orally once daily over…
Diabetes
A 24-week, randomized, double-blind, active-controlled, parallel group trial to assess the superiority of oral linagliptin and metformin compared to linagliptin monotherapy in newly diagnosed, treatmentnaïve, uncontrolled Type 2 Diabetes Mellitus patients. Register Today!
Gout
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects with Gout who have had an Inadequate Hypouricemic Response to Standard of Care Allopurinol. Register Today!
Seasonal Influenza Vaccine
A Phase III, double-blind, randomised, controlled, multi-country, multi-centre study to evaluate the immunogenicity and safety of GSK Biologicals’ quadrivalent influenza vaccine candidate, GSK2282512A (FLU Q-QIV), compared to GSK Biologicals’ trivalent influenza vaccine Fluarix®, administered intramuscularly to children 6 to 35 months of age. Register Today!
Moderate to severe COPD
A Randomized, Blinded, Double-dummy, Parallel-group Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg compared with Tiotropium 18 mcg in Subjects with Chronic Obstructive Pulmonary Disease (COPD). Register Today!
Type II Diabetes in Renal Failure (M11-352)
Kidneys are remarkable organs. Inside them are millions of tiny blood vessels that act as filters. Their job is to remove waste products from the blood. Sometimes this filtering system breaks down. Diabetes can damage the kidneys and cause them to fail. Failing kidneys lose their ability to filter out waste products, resulting in kidney…
COPD (CTT116855)
People with COPD usually have one or more of these symptoms: a cough that lasts a long time (longer than 3 months) a cough with mucus feeling short of breath lung infections (the flu, acute bronchitis, pneumonia, etc) that may last longer than other people you know wheezing (a whistling sound when you breathe) feeling…
Peripheral Artery Disease (COMPASS)
A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS – Cardiovascular OutcoMes for People using Anticoagulation Strategies) Click here for more information. Register Today!